Summary Brainsway Ltd. (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company offers deep transcranial magnetic stimulation products. Its deep TMS is used for treatment of depressive episodes in adult patients suffering from depressive disorder. Brainsway runs various clinical research programs. The company also operates online portals for patients, physicians and researchers. It collaborates with various institutions and researchers in clinical trials covering various neuropsychiatric and neuroscience applications. Brainsway is headquartered in Jerusalem, Israel. This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes... Research Beam Model: Research Beam Product ID: 712906 750 USD New
Brainsway Ltd. (BRIN) - Product Pipeline Analysis, 2016 Update
 
 

Brainsway Ltd. (BRIN) - Product Pipeline Analysis, 2016 Update

  • Category : Pharmaceuticals
  • Published On : August   2016
  • Pages : 33
  • Publisher : GlobalData
 
 
 
Summary

Brainsway Ltd. (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company offers deep transcranial magnetic stimulation products. Its deep TMS is used for treatment of depressive episodes in adult patients suffering from depressive disorder. Brainsway runs various clinical research programs. The company also operates online portals for patients, physicians and researchers. It collaborates with various institutions and researchers in clinical trials covering various neuropsychiatric and neuroscience applications. Brainsway is headquartered in Jerusalem, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Brainsway Ltd.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Brainsway Ltd. Company Snapshot 5
Brainsway Ltd. Company Overview 5
Brainsway Ltd. Pipeline Products and Clinical Trials Overview 6
Brainsway Ltd. – Pipeline Analysis Overview 8
Key Facts 8
Brainsway Ltd. - Major Products and Services 9
Brainsway Ltd. Pipeline Products by Development Stage 10
Brainsway Ltd. Clinical Trials by Trial Status 12
Brainsway Ltd. Pipeline Products Overview 14
Deep TMS System - Alzheimer's Disease 14
Deep TMS System - Alzheimer's Disease Product Overview 14
Deep TMS System - Autism 15
Deep TMS System - Autism Product Overview 15
Deep TMS System - Bipolar Disorder 16
Deep TMS System - Bipolar Disorder Product Overview 16
Deep TMS System - Bipolar Disorder Clinical Trial 17
Deep TMS System - MS 18
Deep TMS System - MS Product Overview 18
Deep TMS System - OCD 19
Deep TMS System - OCD Product Overview 19
Deep TMS System - OCD Clinical Trial 20
Deep TMS System - PTSD 21
Deep TMS System - PTSD Product Overview 21
Deep TMS System - PTSD Clinical Trial 22
Deep TMS System - Smoking Cessation 23
Deep TMS System - Smoking Cessation Product Overview 23
Deep TMS System - Smoking Cessation Clinical Trial 24
Deep TMS System - Stroke 25
Deep TMS System - Stroke Product Overview 25
Brainsway Ltd. - Key Competitors 26
Brainsway Ltd. - Key Employees 27
Brainsway Ltd. - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Brainsway Ltd., Recent Developments 29
Jun 01, 2016: Brainsway announces resignation of Guy Ezekiel, president and CEO 29
Jun 01, 2016: Brainsway Announces Doubled Revenue in First Quarter 29
Dec 08, 2015: Brainsway Opens Mexico market through an Exclusive Distribution Agreement with moksha8 29
Nov 19, 2015: NeuroMed TMS Centers Partners With Brainsway to Provide Deep Transcranial Magnetic Stimulation to Those Suffering From Depression 29
Oct 06, 2015: Brainsway Partners With U.S Navy to Provide Innovative Deep Transcranial Magnetic Stimulation for Depression Treatment 30
Sep 10, 2015: Brainsway Expands Management Team With Appointment of Joseph Perekupka as VP of Sales Operations, North America 30
Aug 17, 2015: Brainsway Appoints Avi Pozan as VP Global Sales 31
Jul 16, 2015: Brainsway Deep TMS covered by Blue Cross Blue Shield North Carolina 31
Jul 02, 2015: Brainsway's Deep TMS treatment now covered by Humana for severe depression patients 31
Jun 29, 2015: Brainsway Receives ARTG Approval for Marketing its Deep TMS Treatment for Depression in Australia 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List Of Tables
List of Tables
Brainsway Ltd. Pipeline Products and Clinical Trials Overview 6
Brainsway Ltd. Pipeline Products by Equipment Type 6
Brainsway Ltd. Pipeline Products by Indication 7
Brainsway Ltd. Clinical Trials by Trial Status 7
Brainsway Ltd., Key Facts 8
Brainsway Ltd., Major Products and Services 9
Brainsway Ltd. Number of Pipeline Products by Development Stage 10
Brainsway Ltd. Pipeline Products Summary by Development Stage 11
Brainsway Ltd. Clinical Trials by Trial Status 12
Brainsway Ltd. Clinical Trials Summary 13
Deep TMS System - Alzheimer's Disease - Product Status 14
Deep TMS System - Alzheimer's Disease - Product Description 14
Deep TMS System - Autism - Product Status 15
Deep TMS System - Autism - Product Description 15
Deep TMS System - Bipolar Disorder - Product Status 16
Deep TMS System - Bipolar Disorder - Product Description 16
Deep TMS System - Bipolar Disorder - Evaluation Clinical, Cognitive and Safety in the Treatment of Bipolar Depression with H1-Coil Deep Transcranial Magnetic Stimulation 17
Deep TMS System - MS - Product Status 18
Deep TMS System - MS - Product Description 18
Deep TMS System - OCD - Product Status 19
Deep TMS System - OCD - Product Description 19
Deep TMS System - OCD - Tolerability, Safety and Efficacy of the HAC-coil Deep Transcranial Magnetic Stimulation in Medication Resistance Obsessive Compulsive Disorder (OCD) Subjects 20
Deep TMS System - PTSD - Product Status 21
Deep TMS System - PTSD - Product Description 21
Deep TMS System - PTSD - A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Brainsway (HAC-Coil) Deep Transcranial Magnetic Stimulation (DTMS) System for the Treatment of Post-traumatic Stress Disorder (PTSD) 22
Deep TMS System - PTSD - Multi-center Investigational Device Exemption Study of Brainsway's Deep Transcranial Magnetic Stimulation for Treatment of Post Traumatic Stress Disorder 22
Deep TMS System - Smoking Cessation - Product Status 23
Deep TMS System - Smoking Cessation - Product Description 23
Deep TMS System - Smoking Cessation - A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Deep Transcranial Magnetic Stimulation (DTMS) (with the H-ADD Coil) Intended as an Aid to Smoking Cessation 24
Deep TMS System - Stroke - Product Status 25
Deep TMS System - Stroke - Product Description 25
Brainsway Ltd., Key Employees 27
Brainsway Ltd., Subsidiaries 28
Lisst Of Figures
List of Figures
Brainsway Ltd. Pipeline Products by Equipment Type 7
Brainsway Ltd. Pipeline Products by Development Stage 10
Brainsway Ltd. Clinical Trials by Trial Status 12
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter